RasGRP1 agonists stimulate P-TEFb biogenesis via MEK-ERK-mTORC1 signaling to reverse HIV latency with minimal CD4 downregulation
Authors:
Preprint
Abstract
Reactivation of latent HIV to facilitate clearance of persisting infected cells requires identifying non-toxic latency-reversing agents (LRAs) that activate P-TEFb, a cellular transcription factor essential for efficient HIV RNA synthesis. Diacylglycerol (DAG)-mimicking PKC agonists induce P-TEFb to reverse HIV latency mainly through a PKC-independent RasGRP1-Ras-Raf-MEK-ERK1/2 pathway, but also elicit global T-cell activation and a drastic downregulation of CD4 receptors. Here, we demonstrate that synthetic DAG-indololactones, which preferentially bind RasGRP1 over PKC by up to 60-fold, strongly induce posttranscriptional P-TEFb expression in memory CD4+ T cells via MEK-ERK1/2-mTORC1 signaling without triggering T-cell activation markers and with minimal CD4 loss. Elevation of T-cell activation markers by natural and synthetic PKC agonists proceeds through MEK-ERK1/2 but is independent of mTORC1 activity. Combinations of the DAG-indololactone 2A127 and HDAC inhibitors synergistically reactivate latent HIV in a primary T-cell model and CD4+ T cells from treated individuals. These findings suggest that a combination LRA approach targeting P-TEFb production through RasGRP1-ERK1/2-mTORC1 signaling and the epigenetic activation of proviral HIV can efficiently and safely reverse HIV latency.Keywords
This publication has 72 references indexed in Scilit:
- Synthesis and evaluation of DAG-lactone derivatives with HIV-1 latency reversing activityEuropean Journal of Medicinal Chemistry, 2023
- Evaluation of synergism in drug combinations and reference models for future orientations in oncologyCurrent Research in Pharmacology and Drug Discovery, 2022
- A Reliable Primary Cell Model for HIV Latency: The QUECEL (Quiescent Effector Cell Latency) Method2022
- Single-Molecule Imaging Reveals Translation of mRNAs Localized to Stress GranulesCell, 2020
- The Translational Machinery of Human CD4+ T Cells Is Poised for Activation and Controls the Switch from Quiescence to Metabolic RemodelingCell Metabolism, 2018
- Exploring the influence of indololactone structure on selectivity for binding to the C1 domains of PKCα, PKCε, and RasGRPBioorganic & Medicinal Chemistry, 2017
- Analysis of drug combinations: current methodological landscapePharmacology Research & Perspectives, 2015
- Phosphorylation of HEXIM1 at Tyr271 and Tyr274 Promotes Release of P‐TEFb from the 7SK snRNP Complex and Enhances Proviral HIV Gene ExpressionProteomics, 2015
- Synthesis, biological, and biophysical studies of DAG-indololactones designed as selective activators of RasGRPBioorganic & Medicinal Chemistry, 2014
- Phosphorylation and Functional Inactivation of TSC2 by ErkCell, 2005